These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 804818)

  • 1. Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice.
    Kreutner W; Springer SC; Sherwood JE
    Am J Physiol; 1975 Feb; 228(2):663-71. PubMed ID: 804818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose load diverts hepatic gluconeogenic product from glucose to glycogen in vivo.
    Shikama H; Ui M
    Am J Physiol; 1978 Oct; 235(4):E354-60. PubMed ID: 100016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats.
    Torres TP; Fujimoto Y; Donahue EP; Printz RL; Houseknecht KL; Treadway JL; Shiota M
    Diabetes; 2011 Sep; 60(9):2225-33. PubMed ID: 21771972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of short-term fasting in obese hyperglycaemic humans and mice.
    Belfiore F; Iannello S; Rabuazzo AM; Campione R
    Int J Obes; 1987; 11(6):631-40. PubMed ID: 2831163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
    Rossetti L; Giaccari A; Barzilai N; Howard K; Sebel G; Hu M
    J Clin Invest; 1993 Sep; 92(3):1126-34. PubMed ID: 8397219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice.
    Bandsma RH; Grefhorst A; van Dijk TH; van der Sluijs FH; Hammer A; Reijngoud DJ; Kuipers F
    Diabetologia; 2004 Nov; 47(11):2022-31. PubMed ID: 15599701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in obesity: a critical analysis at enzyme level. A review.
    Belfiore F; Iannello S; Rabuazzo AM
    Int J Obes; 1979; 3(4):301-23. PubMed ID: 393647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate metabolism of the isolated perfused liver of normal and genetically obese--hyperglycaemic (ob-ob) mice.
    Elliott J; Hems DA; Beloff-Chain A
    Biochem J; 1971 Dec; 125(3):773-80. PubMed ID: 5145897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus.
    Andrikopoulos S; Proietto J
    Diabetologia; 1995 Dec; 38(12):1389-96. PubMed ID: 8786011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice.
    Chen C; Williams PF; Cooney GJ; Caterson ID; Turtle JR
    Horm Metab Res; 1992 Apr; 24(4):161-6. PubMed ID: 1601390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycerol-3-phosphate dehydrogenase 1 deficiency induces compensatory amino acid metabolism during fasting in mice.
    Sato T; Yoshida Y; Morita A; Mori N; Miura S
    Metabolism; 2016 Nov; 65(11):1646-1656. PubMed ID: 27733253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Gilchrist BJ; Wyse BM
    Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of glycerol and alanine to basal hepatic glucose production in the genetically obese (fa/fa) rat.
    Terrettaz J; Jeanrenaud B
    Biochem J; 1990 Sep; 270(3):803-7. PubMed ID: 2241912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adrenalectomy on the metabolism of glucose in obese (C57 Bl/6J ob/ob) mice.
    Wittmers LE; Haller EW
    Metabolism; 1983 Dec; 32(12):1093-100. PubMed ID: 6645960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.
    Giaccari A; Rossetti L
    J Clin Invest; 1992 Jan; 89(1):36-45. PubMed ID: 1530852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the availability of substrates on hepatic and renal gluconeogenesis in the fasted late pregnant rat.
    Zorzano A; Lasunción MA; Herrera E
    Metabolism; 1986 Apr; 35(4):297-303. PubMed ID: 3959901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Gluconeogenic Response to Single and Long-Term SGLT2 Inhibition in Lean/Obese Male Hepatic G6pc-Reporter Mice.
    Inaba Y; Hashiuchi E; Watanabe H; Kimura K; Sato M; Kobayashi M; Matsumoto M; Kitamura T; Kasuga M; Inoue H
    Endocrinology; 2019 Dec; 160(12):2811-2824. PubMed ID: 31517956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
    Edgerton DS; Cardin S; Neal D; Farmer B; Lautz M; Pan C; Cherrington AD
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E510-22. PubMed ID: 14644767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice.
    Massillon D; Chen W; Hawkins M; Liu R; Barzilai N; Rossetti L
    Am J Physiol; 1995 Dec; 269(6 Pt 1):E1037-43. PubMed ID: 8572194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.